ARTV
Artiva Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.19
+0.58%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-26.1%
Return on equity
-24.6%
Return on assets
-26.9%
Return on invested capital
0.00x
Asset turnover
-$96.2M
Cash from operations
$7.15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026